Prot #NIS-TRALO-2213: Tralokinumab ReAl world Clinical usE: An observational cohort study of atopic dermatitis patients prescribed tralokinumab (TRACE)

Project: Research project

Project Details

StatusActive
Effective start/end date12/5/2212/5/25

Funding

  • Outcome Sciences Inc. (NIS-TRALO-2213 // NIS-TRALO-2213)
  • LEO Pharma A/S (NIS-TRALO-2213 // NIS-TRALO-2213)